An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 69, Issue 15, 2006, Pages 1481-1495

  Geier, David ^a,b   Geier, Mark ^c  

^a MedCon Inc   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c Genetic Centers of America   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; THIOMERSAL; BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; DIPHTHERIA TETANUS PERTUSSIS HAEMOPHILUS B CONJUGATE VACCINE; DIPHTHERIA-TETANUS-PERTUSSIS-HAEMOPHILUS B CONJUGATE VACCINE; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE VACCINE; HAEMOPHILUS VACCINE; PRESERVATIVE;

ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CLINICAL RESEARCH; COMPARATIVE STUDY; CONJUNCTIVITIS; DEVELOPMENTAL DISORDER; FEBRILE CONVULSION; FEMALE; HUMAN; INFANTILE SPASM; MALE; MANDATORY PROGRAM; MENTAL DEFICIENCY; NEUROTOXICITY; ONLINE ANALYSIS; POSTVACCINAL ENCEPHALITIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REFERENCE DATABASE; REVACCINATION; SPEECH DISORDER; SYSTEMATIC ERROR; THOUGHT DISORDER; TOXICOKINETICS; URINARY TRACT INFECTION; VACCINATION REACTION; CHEMICALLY INDUCED DISORDER; DATA BASE; INFANT; NEUROLOGIC DISEASE; PRESCHOOL CHILD; UNITED STATES;

HAEMOPHILUS INFLUENZAE SEROTYPE B;

BACTERIAL VACCINES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DATABASES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HAEMOPHILUS VACCINES; HUMANS; INFANT; MALE; NERVOUS SYSTEM DISEASES; POLYSACCHARIDES, BACTERIAL; PRESERVATIVES, PHARMACEUTICAL; THIMEROSAL; UNITED STATES;

EID: 33746760276     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390500364556     Document Type: Article

References (58)

1. Andrews, N., Miller, E., Grant, A., Stowe, J., Osborne, V., and Taylor, B. 2004. Thimerosal exposure in infants and developmental disorders: A retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114:584-591
2. Ball, L. K., Ball, R., and Pratt, R. D. 2001. An assessment of Thimerosal use in childhood vaccines. Pediatrics 107:1147-1154.
3. Baskin, D. S., Ngo, H., and Didenko, V. V. 2003. Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts. Toxicol. Sci. 74:361-368.
4. Bernard, S., Enayati, A., Redwood, L., Roger, H., and Binstock, T. 2001. Autism: A novel form of mercury poisoning. Med. Hypoth. 56:462-471.
5. Bernard, S., Enayati, A., Roger, H., Binstock, T., and Redwood, L. 2002. The role of mercury in the pathogenesis of autism. Mol. Psychiat. 7 (suppl. 2):S42-S43.
6. Bertrand, J., Mars, A., Boyle, C., Bove, F., Yeargin-Allsopp, M., and Decoufle, P. 2001. Prevalence of autism in a United States population: The Brick Township, New Jersey, investigation. Pediatrics 108:1155-1161.
7. Blaxill, M. F. 2004. What's going on? The question of time trends in autism. Public Health Rep. 119:536-551.
8. Blaxill, M. F., Baskin, D. S., and Spitzer, W. O. 2003. Commentary: Blaxill, Baskin, and Spitzer on Croen et al. (2002), the changing prevalence of autism in California. J. Autism Dev. Disord. 33:223-226.
9. Blaxill, M. F., Redwood, L., and Bernard, S. 2004. Thimerosal and autism? A plausible hypothesis that should not be dismissed. Med. Hypoth. 62:788-794.
10. Boris, M., Goldblatt, A., Galanko, J., and James, S. J. 2004. Association of 5,10-methylenetetrathydrofolate reductase (MTHFR) gene polymorphisms with autistic spectrum disorders. J. Am. Phys. Surg. 9:106-108.
11. Bradstreet, J., Geier, D. A., Kartzinel, J. J., Adams, J. B., and Geier, M. R. 2003. A case-control study of mercury burden in children with autistic spectrum disorders. J. Am. Phys. Surg. 8:76-79.
12. Brunner, M., Albertini, S., and Wurgler, F. E. 1991. Effects of 10 known or suspected spindle poisons in the in vitro porcine brain tubulin assembly assay. Mutagenesis 6:65-70.
13. Burbacher, T. M., Shen, D. D., Liberato, N., Grant, K. S., Cernichiari, E., and Clarkson, T. W. 2005. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing Thimerosal. Environ. Health Perspect. 113:1015-1021.
14. California Department of Developmental Services. 2003. Autistic spectrum disorders - Changes in the California caseload - An update: 1999 Through 2002. Sacramento: State of California.
15. Chen, R., and Rosenthal, S. 1996. An errant critique that misses the mark. Arch. Pediatr. Adolesc. Med. 150:464-465.
16. Clarkson, T. W., Nordberg, F. J., and Sager, P. R. 1985. Reproductive and developmental toxicity of metals. Scand. J. Work Environ. Health 11:145-154
17. Deth, R. C. and Waly, M. 2004. How genetic risks combine with Thimerosal to inhibit methionine synthase and cause autism. DAN! Conference Proceedings - Fall 2004, pp. 161-174. Los Angeles: Autism Research Institute.
18. Digar, A., Sensharma, G. C., and Samal, S. N. 1987. Lethality and teratogenecity of organic mercury (Thimerosal) on the chick embryo. J. Anat. Soc. India 36:153-159.
19. Environmental Working Group. 2004. Overloaded? New science, new insights about mercury and autism in susceptible children. Washington, DC: EWG Action Fund.
20. Gasset, A. R., Itoi, M., Ishii, Y., and Ramer, R. M. 1975. Teratogenicities of ophthalmic drugs. II. Teratogenicities and tissue accumulation of Thimerosal. Arch. Ophthalmol. 93:52-55.
21. Geier, M. R., and Geier, D. A. 2003a. Neurodevelopmental disorders after Thimerosal-containing vaccines: A brief communication. Exp. Biol. Med. 228:660-664.
22. Geier, D. A., and Geier, M. R. 2003b. An assessment of the impact of Thimerosal on neurodevelopmental disorders. Pediatr. Rehabil. 6:97-102.
23. Geier, M. R., and Geier, D. A. 2003c. Thimerosal in childhood vaccines, neurodevelopment disorders, and heart disease in the United States. J. Am. Phys. Surg. 8:6-11.
24. Geier, D. A., and Geier, M. R. 2004a. A review of the Vaccine Adverse Event Reporting System database. Expert Opin. Pharmacother. 5:691-698.
25. Geier, D. A., and Geier, M. R. 2004b. A comparative evaluation of the effects of MMR immunization and mercury doses from Thimerosal-containing childhood vaccines on the population prevalence of autism. Med. Sci. Monit. 10:PI33-PI39.
26. Geier, D. A., and Geier, M. R. 2004c. Neurodevelopmental disorders following Thimerosal-containing childhood immunizations: a follow-up analysis. Int. J. Toxicol. 23:369-376.
27. Geier, D. A., and Geier, M. R. 2005a. A two-phased population epidemiological study of the safety of Thimerosal-containing vaccines: a follow-up analysis. Med. Sci. Monit. 11:CR160-CR170.
28. Geier, D. A., and Geier, M. R. 2005b. The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Med. Hypoth. 64:946-954.
29. Gerlai, R., and Gerlai, J. 2003. Autism: a large unmet medical need and a complex research problem. Physiol. Behav. 79:461-470.
30. Gerlai, R., and Gerlai, J. 2004. Autism: A target for pharmacotherapies? Drug Discov. Today 9:366-374.
31. Grandjean, P., Weihe, P., White, R. F., and Debes, F. 1998. Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ. Res. 77:165-172.
32. Heron J., Golding, J., and ALSPAC Study Team. 2004. Thimerosal exposure in infants and developmental disorders: A prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114:577-583.
33. Hill, A. B. 1965. The environment and disease: association or causation. Proc. R. Soc. Med. 58:295-300.
34. Holmes, A. S., Blaxill, M. F., and Haley, B. E. 2003. Reduced levels of mercury in first baby haircuts of autistic children. Int. J. Toxicol. 22:277-285.
35. Hornig, M., Chian, D., and Lipkin, W. I. 2004. Neurotoxic effects of postnatal Thimerosal are mouse strain dependent. Mol. Psychiat. 9:833-845.
36. Humphrey, M. L., Cole, M. P., Pendergrass, J. C., and Kiningham, K. K. 2005. Mitochondrial mediated Thimerosal-induced apoptosis in a human neuroblastoma cell line (SK-N-SH). Neurotoxicology 26:407-416.
37. Hviid, A., Stellfeld, M., Wohlfahrt, J., and Melbye, M. 2003. Association between Thimerosal-containing vaccine and autism. J. Am. Med. Assoc. 290:1763-1766.
38. Institute of Medicine. 2004. Immunization safety review: Vaccines and autism. Washington, DC: National Academy Press.
39. Institute of Medicine. 2005. Review of the National Immunization Program's research procedures and data sharing program: Vaccine safety research, data access, and public trust. Washington, DC: National Academy Press.
40. James, S. J., Laurette, J., Melnyk, S., and Culter, P. 2004. Impaired methylation capacity and increased oxidative stress in children with autism: Metabolic biomarkers and genetic predisposition. Am. J. Clin. Nutr. 80:1611-1617.
41. James, S. J., Slikker, W., Melnyk, S., New, E., Pogribna, M., and Jernigan, S. 2005. Thimerosal neurotoxicity is associated with glutathione depletion: Protection with glutathione precursors. Neurotoxicology 26:1-8.
42. Leong, C. C., Syed, N. I., and Lorscheider, F. L. 2001. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. NeuroReport 12:733-737.
43. Lloyd, J. C., Haber, P., Mootrey, G. T., Braun, M. M., Rhodes, P. H., Chen, R. T., and VAERS Working Group. 2003. Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: Data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997. Vaccine 21:3746-3750.
44. Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., Plesner, A. M., Andersen, P. H., and Mortensen, P. B. 2003. Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics 112:604-606.
45. Newschaffer, C. J., Falb, M. D., and Gurney, J. G. 2005. National autism prevalence trends from United States special education data. Pediatrics 115:e277-e282.
46. Parran, D. K., Barker, A., and Ehrich, M. 2005. Effects of Thimerosal on NGF signal transduction and cell death in neuroblastoma cells. Toxicol. Sci. 86:132-140.
47. Parry, J. M. 1993. An evaluation of the use of in vitro tubulin polymerisation, fungal and wheat assays to detect the activity of potential chemical aneugens. Mutat. Res. 287:23-28.
48. Redwood, L., Bernard, S., and Brown, D. 2001. Predicted mercury concentrations in hair from infant immunizations: Cause for concern. Neurotoxicology 22:691-697.
49. Rosenthal, S., Chen, R., and Hadler, S. 1996. The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. Arch. Pediatr. Adolesc. Med. 150:457-460.
50. Sager, P. R., Aschner, M., and Rodier, P. M. 1984. Persistent, differential alterations in developing cerebellar cortex of male and female mice after methylmercury exposure. Brain Res. 314:1-11.
51. Singleton, J. A., Lloyd, J. C., Mootrey, G. T., Salive, M. E., and Chen, R. T. 1999. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine 17:2908-2917.
52. Slikker, W. 2000. Developmental neurotoxicology of therapeutics: Survey of novel recent findings. Neurotoxicology 21:250.
53. Stehr-Green, P., Tull, P., Stellfeld, M., Mortenson, P. B., and Simpson, D. 2003. Autism and Thimerosal-containing vaccines: Lack of consistent evidence for an association. Am. J. Prev. Med. 25:101-106.
54. Verstraeten, T. 2004. Thimerosal, the Centers for Disease Control and Prevention, and GlaxoSmithKline. Pediatrics 113:932.
55. Verstraeten, T., Davis, R. L., DeStefano, F., Lieu, T. A., Rhodes, P. H., Black, S. B., Shinefield, H., Chen, R. T., and Vaccine Safety Datalink Team. 2003. Safety of Thimerosal-containing vaccines: A two-phased study of computerized health maintenance organization databases. Pediatrics 112:1039-1048.
56. Wallin, M., and Hartely-Asp, B. 1993. Effects of potential aneuploidy inducing agents on microtubule assembly in vitro. Mutat. Res. 287:17-22.
57. Waly, M., Olteanu, H., Banerjee, R., Choi, S. W., Mason, J. B., Parker, B. S., Sukumar, S., Shim, S., Sharma, A., Benzecry, J. M., Power-Charnitsky, V. A., and Deth, R. C. 2004. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: A target for neurodevelopmental toxins and Thimerosal. Mol. Psychiat. 9:358-370.
58. Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., and Murphy, C. 2003. Prevalence of autism in a US metropolitan area. J. Am. Med. Assoc. 289:49-55.